Abstract
The state-dependent effect of the BZ-receptor agonist diazepam (1.25–10 mg/kg), the partial agonist FG 8205 (0.5–4.0 mg/kg) and the BZ1-receptor agonist zolpidem (0.25–2 mg/kg) were investigated in rats. During daily sessions, animals were trained to acquire FR10 lever pressing for food reinforcement whilst under the influence of the agonists, using an operant technique. Forty-eight hours after the final training session under drug, their performance of the FR10 was evaluated during a test session, carried out following vehicle administration only. Neither diazepam, nor FG 8205 impaired acquisition of the task. In the group treated with 2 mg/kg zolpidem, six out of eight rats failed to learn within 20 sessions, but the smaller doses were without effect on acquisition. When drug treatment was withdrawn, there was evidence that all three of the agonists tested produced state-dependency. This was apparent in the form of longer latencies to obtain reinforcement and decreased lever pressing rates. The significance of these findings are discussed in the context of the relationship between the state-dependent effects of BZ-receptor agonists and their other properties, and the receptor subtypes which might underly these effects.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Andrews N, File SE (1992) Are there changes in sensitivity to 5-HT3 receptor ligands following chronic diazepam treatment? Psychopharmacology 108:333–337
Barrett RJ, Smith RL (1988) Time dependent pentylenetetrazol-like cues subsequent to diazepam administration. Psychopharmacology 96:169–173
Benavides J, Peny B, Dubois A, Perrault G, Morel E, Zivkovic B, Scatton B (1988) In vivo interaction of zolpidem with central benzodiazepine (BZD) binding sites (as labeled by [3H]Ro 15-1788) in the mouse brain. Preferential affinity of zolpidem for the ω1(BZD1) subtype. J Pharmacol Exp Ther 245:1033–1041
Colpaert FC (1986) A method for quantifying state-dependency with chlordiazepoxide in rats. Psychopharmacology 90:144–146
Colpaert FC (1990) Amnesic trace locked into the benzodiazepine state of memory. Psychopharmacology 102:28–36
Dawson GR, Bayley PJ, Tricklebank MD (1993) The effect of the partial benzodiazepine receptor agonist FG8205 and diazepam in rodent models of sedation. Br Pharmacol 108:48P
Depoortere H, Zivkovic B, Lloyd KG, Sanger DJ, Perrault G, Langer SZ, Bartholini G (1986) Zolpidem, a novel nonbenzodiazepine hypnotic. I. Neuropharmacological and behavioural effects. J Pharmacol Exp Ther 237:649–658
DiScala G, Angst MJ, Sandner G (1993) State dependent fear extinction: differential effects of anxiolytic drugs. Behav Pharmacol 4:459
File SE, Mabbutt PS, Andrews N (1991) Diazepam withdrawal responses measured in the social interaction test of anxiety and their reversal by baclofen. Psychopharmacology 104:62–66
Gardner CR, Mann G (1986) Incomplete overlap of interoceptive stimuli induced by CL 218872 and chlordiazepoxide. Br J Pharmacol 89:867P
Goudie AJ, Harrison AA, Leathley MJ (1993) Evidence for a dissociation between benzodiazepine withdrawal signs. NeuroReport 4:295–298
Haefely W, Martin JR, Schoch P (1990) Novel anxiolytics that act as partial agonists at benzodiazepine receptors. Trends Pharmacol Sci 11:452–456
Jackson A, Koek W, Colpaert FC (1992) NMDA antagonists make learning and recall state-dependent. Behav Pharmacol 3:415–421
Jackson A, Tattersall FD, Bentley G, Rycroft W, Bourson A, Hargreaves R, Tricklebank MD, Iversen SD (1994) An investigation into the discriminative stimulus and reinforcing properties of the CCKB-receptor antagonist, L-365,260, in rats. Neuropeptides 26:343–353
Jensen HH, Poulsen JC (1982) Amnesic effects of diazepam: “Drug dependence” explained by state-dependent learning. Scand J Psychopharmacol 23:107–111
Lader M, File S (1987) The biological basis of benzodiazepine dependence. Psychol Med 17:539–547
Liljequist R, Linnoila M, Mattila MJ (1977) State-dependent effect of diazepam on learning. Br J Pharmacol 59:518P
Martin WR, McNicholas LF, Cherians S (1982) Diazepam and pentobarbital dependence in the rat. Life Sci 31:721–730
Perrault G, Morel E, Sanger DJ, Zivkovic B (1990) Differences in pharmacological profiles of a new generation of benzodiazepine and non-benzodiazepine hypnotics. Eur J Pharmacol 187:487–494
Perrault G, Morel E, Sanger DJ, Zivkovoc B (1992) Lack of tolerance and physical dependence upon repeated treatment with the novel hypnotic zolpidem. J Pharmacol Exp Ther 263:298–303
Pritchett DB, Seeburg PH (1990) γ-Aminobutyric acidA receptor α5-subunit creates novel type II benzodiazepine receptor pharmacology. J Neurochem 54:1802–1804
Pritchett DB, Luddens H, Seeburg PH (1989a) Type I and type II GABAA-benzodiazepine receptors produced in transfected cells. Science 245:1389–1392
Pritchett DB, Sontheimer H, Shivers BD, Ymer S, Hettenmann H, Schofield PR, Seeburg PH (1989b) Importance of a novel GABAA receptor subunit for benzodiazepine pharmacology. Nature 338:582–585
Sanger DJ (1987) Further investigation of the stimulus properties of chlordiazepoxide and zolpidem. Agonism and antagonism by two novel benzodiazepines. Psychopharmacology 93:365–368
Sanger DJ, Zivkovic B (1987) Investigation of the development of tolerance to the actions of zolpidem and midazolam. Neuropharmacology 26:1513–1518
Sanger DJ, Zivkovic B (1988) Further behavioural evidence for the selective sedative action of zolpidem. Neuropharmacology 27:1125–1130
Sanger DJ, Zivkovic B (1992) Differential development of tolerance to the depressant effects of benzodiazepine and non-benzodiazepine agonists at the omega (BZ) modulatory sites of GABAA receptors. Neuropharmacology 31:693–700
Sanger DJ, Perrault G, Morel E, Joly D, Zivkovic B (1987) The behavioural profile of zolpidem, a novel hypnotic drug of imidazopyridine structure. Physiol Behav 41:235–240
Schofield PR, Darlison MG, Fujita N, Burt DR, Stephenson FA, Rodriquez H, Rhee LM, Ramachandran J, Reale V, Glencorse TA, Seeburg PH, Barnard EA (1987) Sequence and functional expression of the GABAA receptor shows a ligand-gated receptor super-family. Nature 328:221–227
Squires RF, Benson DI, Braestrup C, Coupet J, Klepner CA, Myers V, Beer B (1979) Some properties of brain specific benzodiazepine receptors:new evidence for multiple receptors. Pharmacol Biochem Behav 10:825–830
Stanhope KJ, Roe S, Dawson G, Draper F, Jackson A (1993) Effect of the benzodiazepine receptor agonist, zolpidem, on palatable fluid consumption in the rat. Psychopharmacology 111:185–189
Suzuki T, Fukumori R, Yoshii T, Yanaura S, Satoh T, Kitagawa H (1980) Effect ofp-chlorophenylalanine on diazepam withdrawal signs in rats. Psychopharmacology 71:91–93
Tricklebank MD, Honore T, Iversen SD, Kemp JA, Knight AR, Marshall GR, Rupniak NMJ, Singh S, Tye S, Watjen F, Wong EHF (1990) The pharmacological properties of the imidazobenzodiazepine, FG 8205, a novel partial agonist at the benzodiazepine receptor. Br J Pharmacol 101:753–761
Williamson D, Jackson A, Tricklebank MD (1992) The benzodiazepine receptor agonists FG8205 and diazepam may exert their anticonvulsant action via different mechanisms. Br J Pharmacol 107:351P
Woods JH, Katz JL, Winger G (1987) Abuse liability of benzodiazepines. Pharmacol Rev 29:251–413
Woods JH, Katz JL, Winger G (1992) Benzodiazepines: use, abuse and consequences. Pharmacol Rev 44:151–347
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Jackson, A. State-dependent effects of atypical benzodiazepine-receptor agonists. Psychopharmacology 119, 399–404 (1995). https://doi.org/10.1007/BF02245855
Received:
Revised:
Issue Date:
DOI: https://doi.org/10.1007/BF02245855